The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 6/Signature 1
From BugSigDB
< The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies | The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 6
Needs review
Source: Figure 7
Description: Results across genus taxonomic rank for DBS and LCIG participants shows the most differentially abundant taxa after the initiation of DBS therapy (t = 0 to t = 12).
Abundance in Group 1: increased abundance in Deep Brain Stimulation DAT patients (t = 0 to t = 12).
| NCBI | Quality Control | Links |
|---|---|---|
| Prevotella | ||
| Methanobrevibacter | ||
| Treponema | ||
| Bacillus | ||
| Veillonella | ||
| Citrobacter | ||
| Faecalicoccus | ||
| Morganella |
Revision editor(s): Bolanle, Fiddyhamma
